与耐多药结核病患者全因死亡率相关的因素-美国，1993-2013 年。
Factors Associated With All-Cause Mortality Among Patients With Multidrug-Resistant Tuberculosis-United States, 1993-2013.
机构信息
Centers for Disease Control and Prevention, Atlanta, Georgia.
出版信息
Clin Infect Dis. 2017 Nov 13;65(11):1924-1926. doi: 10.1093/cid/cix667.
PMID:29020169
Abstract
We assessed characteristics associated with all-cause mortality among US patients with multidrug-resistant tuberculosis. Mortality decreased from 31% during 1993-2002 to 11% during 2003-2013. Directly observed therapy coverage increased from 74% to 95% and was protective against all-cause mortality after accounting for demographics, clinical characteristics, human immunodeficiency virus status, and period of treatment.
摘要
我们评估了与美国耐多药结核病患者全因死亡率相关的特征。死亡率从 1993 年至 2002 年的 31%下降到 2003 年至 2013 年的 11%。直接观察治疗覆盖率从 74%增加到 95%，并且在考虑人口统计学、临床特征、人类免疫缺陷病毒状况和治疗期间后，对全因死亡率具有保护作用。
Zotero 插件